Currie Mark G 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Currie Mark G
Chief Scientific Officer
Transactions
- Award
Class A Common Stock
2025-06-10+45,000→ 613,419 total
Footnotes (1)
- [F1]The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.